Normal view MARC view ISBD view

Resistance in the land of molecular cancer therapeutics.

Shannon, Kevin M

Resistance in the land of molecular cancer therapeutics. [electronic resource] - Cancer cell Aug 2002 - 99-102 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review

ISSN: 1535-6108

Standard No.: 10.1016/s1535-6108(02)00101-0 doi

Subjects--Topical Terms:
Antineoplastic Agents--administration & dosage
Benzamides
Disease Progression
Drug Resistance, Neoplasm--genetics
Fusion Proteins, bcr-abl--chemistry
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Mutation
Piperazines--administration & dosage
Pyrimidines--administration & dosage

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)